Edge Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$9.38M Hold
172,497
0.07% 209
2016
Q4
$10.1M Sell
172,497
-3,542
-2% -$194K 0.08% 212
2016
Q3
$9.49M Sell
176,039
-175,728
-50% -$11.3M 0.08% 219
2016
Q2
$25.9M Buy
351,767
+82,298
+31% +$5.82M 0.23% 129
2016
Q1
$17.2M Sell
269,469
-3,007
-1% -$190K 0.17% 169
2015
Q4
$18.7M Sell
272,476
-50,987
-16% -$3.37M 0.18% 152
2015
Q3
$19.1M Sell
323,463
-15,973
-5% -$1.01M 0.19% 144
2015
Q2
$22.6M Buy
339,436
+46,074
+16% +$3.04M 0.2% 141
2015
Q1
$18.9M Sell
293,362
-3,800
-1% -$238K 0.16% 163
2014
Q4
$17.5M Sell
297,162
-331
-0.1% -$18.7K 0.17% 156
2014
Q3
$15.2M Sell
297,493
-7,551
-2% -$377K 0.15% 154
2014
Q2
$14.8M Sell
305,044
-12,400
-4% -$611K 0.15% 147
2014
Q1
$16.5M Sell
317,444
-36,829
-10% -$1.96M 0.17% 125
2013
Q4
$18.8M Sell
354,273
-50,875
-13% -$2.59M 0.2% 111
2013
Q3
$18.8M Sell
405,148
-47,452
-10% -$2.08M 0.22% 106
2013
Q2
$20.2M Buy
+452,600
New +$19.6M 0.25% 104

Other funds holding BMY

Edge Asset Management's BMY Position: Q1 2017 in Review

Edge Asset Management held its Bristol-Myers Squibb (BMY) position steady in Q1 2017 at 172,497 shares worth $9.38M. The position accounts for 0.07% of the portfolio, ranked #209.

Edge Asset Management first reported a position in BMY in Q2 2013 and has held it in 16 quarters since. The position peaked at $25.9M in Q2 2016. 1,598 funds tracked by Wall St. Rank hold BMY as of Q1 2017.

  • Edge Asset Management held 172,497 shares of Bristol-Myers Squibb worth $9.38M as of Q1 2017.
  • Edge Asset Management left its Bristol-Myers Squibb share count unchanged in Q1 2017.
  • Bristol-Myers Squibb made up 0.07% of Edge Asset Management's portfolio in Q1 2017, its #209 holding.
  • Edge Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 16 quarters since.
  • Edge Asset Management's Bristol-Myers Squibb position peaked at $25.9M in Q2 2016.
  • 1,598 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2017.

Based on Edge Asset Management's 13F filing for Q1 2017, filed 11 May 2017.